Senzime brings together the company's clinical monitoring of glucose and lactate under the same trademark - CliniSenz
Uppsala, Sweden, August 26 2015. Senzime have developed user-friendly products for continuous monitoring of glucose and lactate in complex biological fluids such as blood and cell cultures. These measurements are important – and in many cases critical - for patients undergoing surgeries and whom are at risk for unnecessary and dangerous complications if measurements are not managed correctly. Senzime is now collecting the business’ offer for healthcare as one trade mark - CliniSenz.Senzime’s portfolio of measurements for health care has so far been marketed under two brands - CliniSenz (